Westpac Banking Corp’s Ascendis Pharma A/S ASND Stock Holding History

Westpac Banking Corp’s Portfolio ASND Stock Details ASND Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-27,128	Closed	-$2.91M	–	512
2023 Q1	$2.91M	Sell	27,128 -9,614	-26%	-$1.1M	0.04%	460
2022 Q4	$4.49M	Sell	36,742 -44,858	-55%	-$5.21M	0.07%	353
2022 Q3	$8.43M	Buy	81,600 +370	+0.5%	+$35.1K	0.13%	215
2022 Q2	$7.55M	Buy	81,230 +2,834	+4%	+$267K	0.1%	283
2022 Q1	$9.2M	Sell	78,396 -1,936	-2%	-$224K	0.11%	261
2021 Q4	$10.8M	Sell	80,332 -5,763	-7%	-$857K	0.11%	228
2021 Q3	$13.7M	Buy	86,095 +12,655	+17%	+$1.73M	0.15%	181
2021 Q2	$9.66M	Buy	73,440 +851	+1%	+$113K	0.1%	275
2021 Q1	$9.36M	Sell	72,589 -4,938	-6%	-$750K	0.1%	257
2020 Q4	$12.9M	Sell	77,527 -2,916	-4%	-$482K	0.15%	172
2020 Q3	$12.4M	Sell	80,443 -2,009	-2%	-$289K	0.17%	150
2020 Q2	$12.2M	Buy	82,452 +13,420	+19%	+$1.84M	0.18%	146
2020 Q1	$7.77M	Sell	69,032 -14,007	-17%	-$1.82M	0.13%	201
2019 Q4	$11.6M	Buy	83,039 +200	+0.2%	+$22.2K	0.15%	180
2019 Q3	$7.98M	Buy	+82,839	New	+$9.24M	0.11%	260
2019 Q1	–	Sell	-87,160	Closed	-$5.46M	–	728
2018 Q4	$5.46M	Buy	+87,160	New	+$5.48M	0.09%	307

Other funds holding ASND

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Westpac Banking Corp's ASND Position: Q2 2023 in Review

Westpac Banking Corp sold out of Ascendis Pharma A/S (ASND) in Q2 2023, closing a stake of 27,128 shares — an estimated $2.91M sold.

Westpac Banking Corp first reported a position in ASND in Q4 2018 and held it in 16 quarters. The position peaked at $13.7M in Q3 2021. 158 funds tracked by Wall St. Rank hold ASND as of Q2 2023.

Westpac Banking Corp reported no remaining Ascendis Pharma A/S position as of Q2 2023 after selling out during the quarter.
Westpac Banking Corp sold 27,128 Ascendis Pharma A/S shares in Q2 2023, an estimated $2.91M.
Westpac Banking Corp first reported a position in Ascendis Pharma A/S in Q4 2018 and held it in 16 quarters.
Westpac Banking Corp's Ascendis Pharma A/S position peaked at $13.7M in Q3 2021.
158 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2023.

Based on Westpac Banking Corp's 13F filing for Q2 2023, filed 10 Aug 2023.